Ingelheim, Germany and Amsterdam, the Netherlands, 23 April 2025 – Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches ...

The survey confirms differences in perspectives: 65% of animal owners think veterinarians have a good work-life balance 1 while 48% of veterinarians say animal owners underappreciate the way they ...

Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, development, and manufacturing.

German family-owned pharma major Boehringer Ingelheim and Dutch precision oncology company Tessellate Bio have entered into a ...

Boehringer Ingelheim has slipped another piece of its oncology R&D strategy into place, partnering with Tessellate Bio on a ...

Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer ...

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

With a market cap of $775.6 billion, Eli Lilly and Company (LLY) is a global biopharmaceutical leader with leading products ...

Company prepares new product launches starting in 2025.

The "Enterprise Tech Ecosystem Series: Boehringer Ingelheim 2025" company profile has been added to ResearchAndMarkets.com's offering. Boehringer Ingelheim International: Leading the Way in ...

We recently published a list of 10 Best Low Volatility Stocks to Buy Now. In this article, we are going to take a look at ...

Boehringer Ingelheim has launched a new range of cat and dog supplements under the Seraquin brand. The three supplements ...